Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease

British Medical Journal

Volumn 314, Issue 7095, 1997, Pages 1666-1674

  Ebrahim, Shall ^a   Smith, George Davey ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; DIET; EXERCISE; FAMILY COUNSELING; HABITUATION; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; MORTALITY; OCCUPATIONAL HEALTH; PATIENT EDUCATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SMOKING CESSATION; STATISTICS; SYSTOLIC BLOOD PRESSURE;

EID: 0007606130     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.314.7095.1666     Document Type: Article

References (88)

1. Kickbush I. Report on the Adelaide conference. Healthy public policy: second international conference on health promotion, Adelaide, 1988. Adelaide: WHO,1988.
2. Canadian Public Health Association. Ottawa charter for health promotion. Ottawa: Canada, 1986.
3. Trials of coronary heart disease prevention [editorial]. Lancet 1982;ii:803-4.
4. Coronary disease and multiple-risk factor intervention [editorial]. Lancet 1982;i:1395.
5. Puska P, Koskela K, Pakarinen H, Puumalainen P, Soininen V, Tuomilehto J. The North Karelia project: a programme for community control of cardiovascular diseases. Scand J Soc Med 1976;4:57-60.
6. Puska P, Tuomilehto J, Salonen J, Nissinen A, Koskela K, Vartiainen E, et al. Community control of cardiovascular diseases. Tlie North Karelia project Copenhagen: World Health Organisation, 1981:1-351
7. Farquhar J, Wood P, Breitrose H, Haskell W, Meyer A, MacCoby N, et al. Community education for cardiovascular health. Lancet 1977;i:1192-5.
8. Farquhar J, Fortmann S, Flora J, Taylor B, Haskell W, Williams P, et al. Effects of communitywide education on cardiovascular disease risk factors. The Stanford five-city project. JAMA 1990;264:359-65.
9. Fortmann S, Barr Taylor C, Flora J,Jatulis D. Changes in adult cigarette smoking prevalence after 5 years of community health education: the Stanford five-city project. Am J Epidemiol 1993;137:82-96.
10. Double first in Wales [editorial]. BMJ 1984;289:514-515.
11. Secretary of State for Health. The health of the nation. A strategy for health in England. London: HMSO, 1992.
12. Stott N. Screening for cardiovascular risk in general practice. BMJ 1994;308:285-6.
13. Stott N, Kinnersley P, Rollnick S. The limits to health promotion. BMJ 1994;309:971-2.
14. COMMIT Research Group. Community intervention trial for smoking cessation (COMMIT). I. Cohort results from a four year community intervention. Am J Public Health 1995;85:183-92.
15. COMMIT Research Group. Community intervention trial for smoking cessation (COMMIT), II. Changes in adult smoking prevalence. Am J Public Health 1995;85:193-200.
16. Susser M. The tribulations of trials-intervention in communities. Am J Public Health 1995;85:156.
17. McCormick J, Skrabanek P. Coronary heart disease is not preventable by population interventions. Lancet 1988;ii:839-41.
18. Schoenberger J. Cardiovascular risk factors: multiple interventions in man. Clinical and Experimental Hypertension-Theory and Practice 1990;A12:931-8.
19. Research Information Systems. Reference Manager. The bibliographic solution. Carlsbad, CA: Research Information Systems, 1994.
20. Statistics and Epidemiology Research Corporation. EGRET. Reference Manual Seattle, WA: Statistics and Epidemiology Research Corporation. 1992.
21. Fleiss JL, The statistical basis of mcta-analysis. Statistical Metliods in Medical Research 1993;2:121-45.
22. Statistical Package for Social Sciences. SPSS/PC+ Trends. Chicago: SPSS, 1987.
23. World Healtli Organisation European Collaborative Group. Multifactorial trial in the prevention of coronary' heart disease. II. Risk factor changes at two and four years. Eur Heart J 1982;3:184-90.
24. World Health Organisation European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen: WHO, 1989.
25. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, et al. The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 1986;7:279-88.
26. Hjermann I, Holme I, Velve Byre K, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a Randomised Trial in Healthy Men. Lancet 1981;ii:1303-10.
27. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial Risk factor changes and mortality results. JAMA 1982;248:1465-77.
28. Strandberg T, Salomaa V, Naukkarinen V, Vanhancn, Sarna S, Miettinen T. Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. JAMA 1991;266:1225-9.
29. Miettinen T, Huttunen J, Naukkarinen V, Strandberg T, Mattila S, Kundin T, et al. Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence, and mortality. JAMA 1985;251:2097-102.
30. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242:2562-77.
31. Morisky D, Levine D, Green L, Shapiro S, Russell R, Smith C. Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health 1983;73:153-62.
32. Lindholm LU, Ekbom T, Dash C, Eriksson M, Tibblin G, Schersten B. The impact of health care advice given in primary care on cardiovascular risk. BMJ 1993;310:1105-9.
33. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. RMJ 1991;308:308-12.
34. Stamler R, Stamler J, Gosch F, Civinelli J, Fishman J, McKeever P, et al. Primary prevention of hypertension by nutritional hvgicnic means: final report of a randomised controlled trial. JAMA 1989,262:1801-7.
35. Baron J, Glcason R, Crowe B, Mann J. Preliminary trial of the effect of general practice based nutritional advice. Br J Gen Pract 1990;40:137-11.
36. Knutsen S, Knulsen R. The Tromso survey: the family intervention study - the effect of intervention on some coronary risk factors and dietary habits, a 6-year follow-up. Prev Med 1991;20:197-212.
37. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ 1994;308:313-20.
38. Glasgow R, Tergorg J, Hollis J, Severson H, Boles S. Take Heart: results from die initial phase of a vvoik-site wcllness program. Am J Public Health 1993;85:209-16.
39. Carleberg A, Tibblin G. Patient satisfaction in primary health care. A comparative study of two modes of treatment for hypertension. Fam Pract 1992;9:301-10.
40. Martinez-Amenos, Fernandez Ferre M, Mota Vidal C, Alsina Rocasalbas J. Evaluation of two educative models in a primary care hypertension programme. J Hum Hypertens 1990;4:362-4.
41. Blake R. Doyle M, Straub V, Zweig S, Brent E, Ingman S, et al. A randomized controlled evaluation of an educational program in adults with high psychosocial risk of morbidity. Journal of Family Practice 1987;21:369-76.
42. Pierce J, Watson D, Knightsm S, Gliddon T, Williams S, Watson R. A controlled trial of health education in die physician's office. Prev Med 1984;13:185-91.
43. Patterson T, Sallis J, Nader P, Rupp J, McKenzie T, Roppe B, et al. Direct observation of physical activity and dietary behaviours in a structured cm ironment: effects of a family-based health promotion piogram. J Behav Med 1988;11:417-58.
44. Robson J, Boomla K, Fitzpatrick S, Jewell A, Taylor J, Self J, et al. Using nurses for preventive activities with computer assisted follow-up: a randomised controlled trial. BMJ 1989;298:433-6.
45. Edye B, Mandryk J, Frommer M, Healey S, Ferguson D. Evaluation of a worksite programme for the modification of cardiovascular risk factors. Med J Aust 1989;150:574-81.
46. Smith K, McKinlay S. The validity of health risk appraisals for coronary-heart disease: results from a randomised field trial. Am J Public Health 1991;81:4 66-70.
47. Rowland L, Dickinson EJ, Newman P, Ford D, Ebrahim S. Look After Your Heart programme: impact on health status, exercise knowledge, attitudes, and behaviour of retired women in England. J Epidemiol Community Health 1994;48:123-8.
48. Steinbach M, Constantineanu M, Harnagea P, Theodorini S, Georgescu M, Mitu S, et al. The Bucharest multifactorial prevention trial, the changes of morbidity and of general and specific mortality. Revue Roumaine de Médecine-Médecine Interne 1982;20:197-208.
49. Domarkene S, Baubinene A, Chazova L, Kalinina A, Meimanaliev T, Shleifer E, et al. Efficiency of a cooperative program on muhifactor prevention of coronary heart disease. Results of a 3 year follow up. Kardiologia 1990;30:95-8.
50. Fullard E, Fowler G, Gray M. Promoting prevention in primary care: controlled trial of low technology, low cost approach BMJ 1987;291:1080-2.
51. Jula A, Ronnemaa J, Rastas A, Karvetti R-I., Maki J. Long-term nonpharmacological treatment for mild to moderate hypertension. J Intern Med 1990;227:413-21.
52. Gomel M, Oldenburg II, Simpson JM, Owen X. Woik-site cardiovascular risk reduction: a randomised trial of health risk assessment, education, counseling, and incentives. Am] Public Health 1993;R3:1231-8.
53. South East London Screening Study Group A controlled trial of multiphasic screening in middle-age: results of the south-east London screening study. Int J Epidemiol 1977;6:357-63.
54. Lovibond S, Birrell P, Langeluddecke P. Changing coronary heart disease risk-factor status: the effects of three behavioural programs. Journal of Behavioural Medicine 1986;9:414-36.
55. Crouch M, Sallis J, Farquhar JW, Haskell W, Ellsworth N, King A, et al. Personal and mediated healui counseling for sustained dietary reduction of hypercholesterolaemia. Prev Med 1986;15:282-91.
56. Gemson DH, Sloan RP, Messeri P, Goldberg IJ. A public health model for cardiovascular risk reduction. Impact of cholesterol screening with brief nonphysician counseling. Arch Intern Med 1990;150;985-9.
57. Bruno R, Arnold C, Jacobson L, Winick M, Wynder E. Randomized controlled trial of a nonpharmacologic cholesterol reduction program at the worksite. Prev Med 1983;12:523-32.
58. Ostwald SK. Changing employees' dietary and exercise practices: an experimental study in a small company. J. Occup Med 1989;31:90-7.
59. Hanlon P, McEwan J, Gilmour H, Tannahill C, Tannahill A, Kelly M. Health checks and coronary risk: furtlier evidence from a randomised controlled trial. BMJ 1995;311:1609-13.
60. Meimanaliev T, Shleifer E, Aitbaev K, Aitmurzaeva G, Gilfanova V, Podgurskaya L, et al, Prevalence of ischaemic heart disease risk factors among the male population in Frunze aged 40-59 years and results of a five-year prevention programme. COR VASA 1991;33:451-7.
61. Meimanaliev T, Oteva E, Aitbaev K, Maslennikov A, Nikolaeva A, Shterental Ish, et al Prevalence of main risk factors among probands with a history of early myocardial infarction and their relatives. Terapevticheskii Arkhiv 1993;65:28-30.
62. Volozh O. Saava M, Tur I, Xeilinn K, Solodkaia E, Taggerluk H. Risk factors of coronary heart disease and atherosclerosis in Tallin inhabitants-relation of age, sex and ethnic origin. A population study. Kardiologia 1991;31;20-4.
63. Nikitin Y, Bondareva Z, Oteva E, Filimonova T Serum lipid composition in healthy subjects and patients of senile age and long livers. Klinicheskena Meditsina 1991;69:32-5.
64. Jarvis M, West R, Tunstall-Pedoe 11, Vessey C. An equation of the intervention against smoking in the multiple risk factor intervention trial. Prev Med 1984;13:501-9.
65. Egger M, Davey Smith G. Risks and benefits of treating mud hypertension: a misleading ineia-analysis? J Hypertens 1995;13:813-5.
66. Collins R, Peto R, MacMahon S, Herbet P, Fieback X, Eberlein K, et al. Blood pressure, stroke, and coronary heart disease.II. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context Lancet 1990;335:827-38.
67. Collins R, MacMahon S. Blood pressure, antihjpertensh e drug treatment and the risks of stroke and coronary heart disease. Br Med Bull 1994;50:272-98.
68. Law M, Wald N, Thompson S. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367-72.
69. Davey Smith G, Song S, Shcldon T. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ 1993;306:1367-73.
70. Mulrow CD, Cornell JA, Herrcra CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly: implications and generali/ability of randomised triak. JAMA 1995;272:1932-8.
71. Davey Smith G, Egger M. Who benefits from medical interventions? BMJ 1994;308:72-4.
72. Brunner E, White I, Thorogood M, Bristow A, Curle D, Marmot MG. Can dietary interventions in die population change diet and cardiovascular risk factors? An assessment of effectiveness utilising a ineta-analysis of randomised controlled trials, Am J Public Health (in press).
73. Luepker RV, Murray DJacobs D, Mittlcmark NT, Bracht N. Carlaw R, et al. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota heart health program. Am J Public Health 1994;84:1383-93.
74. Luepker RV, Rastam L, Hanham PJ, Murray DM, Gray C. Community education for cardiovascular disease prevenuon: morbidity and mortality results from the Minnesota heart health programme. Am J Epidemiol 1996;144:351-62.
75. Multiple Risk Factor Intervention Trial Research Group. Mortality rates after 10.5 years for participants in the multiple risk factor intervention trial. Findings related to a priori hypotheses of the trial. JAMA 1990;263:1795-801.
76. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 44-14 patients with coronary heart disease: the Scandanaiian simvastatin survival study (4S). Lancet 1991;314:1333-9.
77. Wannamethee G, Shaper AG, Whincup P, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA 1995;274:155-60.
78. Cook D, Shaper AG, Pocock S, Kussick S. Giving up smoking and die risk of heart attacks. Lancet 1986;ii:1376-80.
79. Ben-Shlomo Y, Davey Smith G, Shipley M, Marmot MG. What determines mortality risk in male former cigarette smokers? Am J Public Health 1991;81:1235-42.
80. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 1994;309:23-7.
81. Puska P, Nissinen A, Tuomilehto J. The community based strategy to prevent coronary heart disease conclusions from the ten years of the North Karelia project Annu Rev Public Health 1985;6:147-93.
82. Valkonen T. Trends in regional and socio-economic mortality dilferentials in Finland. International Journal of Health Sciences 1992;3:157-60.
83. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction. Combined experience of randomised clinical trials. JAMA 1988;260:915-50.
84. Mullen PD, Mains DA, Velez R. A meta analysis of controlled trials of cardiac education. Patient Education Counselling 1992;19:143-62.
85. O'Connor GT, Buring JE, Vusuf S, Goldhaber S, Olmstead E, Pafenbarger R, et al. An overview of randomised trials of rehabilitation with exercise after myocardial infarction. Circulation 1989;80:234-44.
86. Cupples M, McKnight Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. BMJ 1994;309:993-6.
87. Rose G. Prevention for individuals and the "high risk" strategy. In: Rose G. The strategy of firei'enteiv medicine. Oxford: Oxford University Press, 1992:29-52.
88. Pearson T, Jamison D, Trejo-Gutierrez J. Cardiovascular disease. In: Jamison D, Moslcy \VH, Measham A, Bobadilla J, eds. Disease, control priorities in developing countries. Oxford: Oxford University Press, 1993:577-91.